Trials / Completed
CompletedNCT01976624
Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 756 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a Post-Marketing Surveillance study to evaluate the safety and efficacy of bimatoprost/timolol (Ganfort®) Ophthalmic Solution to treat open-angle glaucoma or ocular hypertension in Korea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost/timolol | Bimatoprost/timolol (Ganfort®) treatment for open-angle glaucoma or ocular hypertension as per local standard of care in clinical practice. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2013-11-06
- Last updated
- 2015-09-28
- Results posted
- 2015-07-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01976624. Inclusion in this directory is not an endorsement.